Researchers have developed a new hydrogel that can be injected directly to the site of a tumor, where it stays to slowly release its payload of immunotherapy drugs for longer. By doing this, the immunotherapy drugs can gradually and precisely target cancer cells until the job is done. In studies so far, the new form of immunotherapy has been very successful in recognizing and killing cancer cells.